Flu vaccine advisory committee meeting cancellation raises concerns about HHS’ future
Regulatory NewsFerdous Al-Faruque
Advisory committeesBiologics/ biosimilars/ vaccinesGovernment/legislationLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)